Led by Big Pharma's thirst for new biotech products, WTN columnist Michael Rosen reports that biotech financing remains strong despite spotty economic conditions. In this edition of Yer Biotech Blues, Rosen uses information from Wisconsin native and biotech booster Steve Burrill to track some welcome...
Susan Carlson, who has served as director of operations for the WiCell Research Institute, has left WiCell to pursue opportunities in educational publishing. WiCell, a non-profit organization and a subsidiary of the Wisconsin Alumni Research Foundation, was established in 1999 to advance stem cell research...
The state of Wisconsin has qualified two more early-stage technology companies for its Act 255 angel and venture investor program. Joining 73 other certified Wisconsin companies are FluGen of Madison and Sonoplot of Middleton, and investors who make financial commitments to these companies are eligible...
Inviragen, Inc. will receive a $250,000 Technology Venture Fund loan from the Wisconsin Department of Commerce. The Mount Horeb company, founded in 2003, develops vaccines for emerging infectious diseases. ...
Women in Bio have recognized Laura Douglass, president and CEO of Oregon, Wisconsin's Next Generation Clinical Research, as a successful entrepreneur in the life-science industry. She was among 83 women, all founders of biotechnology companies, honored at the organization's recent convention in Washington, D.C. ...
World health experts are concerned that an avian flu pandemic could wreak global havoc, and the rush is on to prevent such a catastrophe. Toward that end, the Gates Foundation has provided a $1.3 million grant to UW-Madison and Lentigen Corp. to donate information and...
The Madison drug-discovery company Centrose has been granted a United States patent for one of its sugar-based drug improvement chemistries. The company, which was spun out of the University of Wisconsin-Madison, has focused on how sugars regulate drug activity in the body....
Okay investors, you have a choice of placing your venture capital bet on one of two companies, each developing a promising therapy for prostrate cancer. Which do you choose? WTN columnist Steven Clark offers an example of how a good scientific understanding of emerging...
Michael Rosen recounts travel in Canada from a biotech and pharma point of view, plus the fruits of his research. Canada is a major U.S. trading partner, and Rosen argues that with the economic expansion of the European Union, the United States needs to look...
Third Wave Technologies announced on Thursday a strategic partnership with DCL Medical Laboratories, in Indianapolis, a reference laboratory focused on women's health. DCL will partner with Third Wave on product development, demonstration and marketing....